NCT06915740 Virtual Pulmonary Rehabilitation Program for COPD Patients; a Pilot Study
| NCT ID | NCT06915740 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Turku University Hospital |
| Condition | COPD (Chronic Obstructive Pulmonary Disease) |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-03-31 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-03-31 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this pilot study is to investigate the feasibility of a virtual rehabilitation program in COPD patients. The main questions it aims to answer are: 1. To facilitate a safe rollout of the remote rehabilitation program for COPD patients in Southwest Finland. 2. To identify and subsequently improve limitations of the rehabilitation program. 3. To evaluate the levels of participant engagement and adherence to the digital COPD rehabilitation program over an extended period to understand its sustainability and long-term impact. 4. To determine the effectiveness of the digital COPD rehabilitation program in improving lung function, exercise capacity, and quality of life among participants 5. To assess the impact of the digital program on healthcare resource utilization, including hospital readmissions, emergency room visits, and outpatient visits related to COPD management. 6. To measure participant satisfaction, usability, and overall experience with the digital platform to identify areas for improvement and enhance user engagement. 7. To evaluate the cost-effectiveness of implementing the digital program compared to conventional rehabilitation methods, considering direct healthcare costs. Participants will be enrolled in a virtual rehabilitation program, and a proportion of the patients is invited for focus group discussion to assess their experiences.
Eligibility Criteria
Inclusion Criteria: 1. Participation in the remote rehabilitation program for COPD patients, fulfilling criteria 1a, 1b and 1c 1a Documented COPD diagnosis (ICD 10 code J44) 1b Expected survival \> 1 year 1c Sufficient technical and language skills for safe participation in the program 2. Signed informed consent Exclusion Criteria: * Severe comorbidities with expected survival of less than 1 year * Clinical suspicion that remote rehabilitation may be unsafe.
Frequently Asked Questions
Who can join the NCT06915740 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying COPD (Chronic Obstructive Pulmonary Disease). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06915740 currently recruiting?
Yes, NCT06915740 is actively recruiting participants. Visit ClinicalTrials.gov or contact Turku University Hospital to inquire about joining.
Where is the NCT06915740 trial being conducted?
This trial is being conducted at Turku, Finland, Turku, Finland.
Who is sponsoring the NCT06915740 clinical trial?
NCT06915740 is sponsored by Turku University Hospital. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.